Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.
Immunological profile of patients with non-cirrhotic portal fibrosis.
J Gastroenterol Hepatol. 1990 Jul-Aug;5(4):425-31. Unique Identifier : AIDSLINE MED/92003430 Sarin SK; Nayyar AK; Malhotra P; Sharma BK; Kumar R; Broor SL; Department of Gastroenterology, G. B. Pant Hospital, New Delhi,; India.
Abstract:
The aetiopathogenesis of non-cirrhotic portal fibrosis (NCPF), a common cause of portal hypertension in India, is not known. To study the immune status of NCPF patients and to see whether immunological mechanisms have a role to play, humoral and cell-mediated immunological studies were carried out in 43 patients with NCPF and compared with equal number of matched healthy controls and 31 patients with compensated liver cirrhosis. Serum immunoglobulin A (IgA) and complement (C3, C4) levels were significantly (P less than 0.001) lower in NCPF patients compared with controls and cirrhotics. There was no significant difference between the total or the relative concentration of the immunoglobulins and complements between NCPF patients and healthy controls, but, in patients with cirrhosis, concentration of all the immunoglobulins was higher. The cutaneous response to dinitrochlorobenzene was poorer in patients with NCPF, but the difference between cirrhotics and controls was not significant. A decrease in the suppressor/cytotoxic (T8) phenotype of lymphocytes in the peripheral blood and an increase in the ratio of helper/inducer (T4) and T8 lymphocytes was seen in patients with NCPF and cirrhosis. Although these results indicate definite immunological abnormalities in NCPF patients, their role in the pathogenesis of NCPF remains to be investigated.
Keywords: Adult Antigen-Antibody Complex/ANALYSIS Comparative Study Complement/ANALYSIS CD4-CD8 Ratio Female Human Hypertension, Portal/EPIDEMIOLOGY/*IMMUNOLOGY Immunoglobulins/ANALYSIS India/EPIDEMIOLOGY Liver Cirrhosis/IMMUNOLOGY Male Skin Tests T-Lymphocyte Subsets JOURNAL ARTICLE
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.